N/A
NPS Score
VS
MyoKardia Claimed Company
- EMPLOYEE
PARTICIPANTS - 2
- TOTAL
RATINGS
Pacira Pharmaceuticals
- EMPLOYEE
PARTICIPANTS - 11
- TOTAL
RATINGS
MyoKardia vs Pacira Pharmaceuticals
Competitors at MyoKardia is not yet available. Get insights into the competitive rankings of MyoKardia CEO Rating, Culture Score, Brand Ranking, and other rankings soon.
MyoKardia
MyoKardia's brand is ranked #- in the list of Global Top 1000 Brands, as rated by customers of MyoKardia. Their current market cap is $11.99B.
Pacira Pharmaceuticals
Pacira Pharmaceuticals's brand is ranked #- in the list of Global Top 1000 Brands, as rated by customers of Pacira Pharmaceuticals. Their current market cap is $3.07B.
4/5
Product Quality
3.2/5
4/5
Pricing
3.2/5
4/5
Customer Service
3.7/5
| 0% | Promoters |
|---|---|
| 0% | Passive |
| 0% | Detractors |
50
NPS Score
| 50% | Promoters |
|---|---|
| 50% | Passive |
| 0% | Detractors |
Net Promoter Score
Winner by 50
See how MyoKardia compares to its competitors
See how Pacira Pharmaceuticals compares to its competitors
Working at MyoKardia vs Working at Pacira Pharmaceuticals
Not enough ratings
CEO Rating
48 / 100
CEO Rating
Winner
MyoKardia
MyoKardia doesn't have enough ratings to calculate the Team Culture Ratings.
Know someone that works there? Invite them to rate their experience.
Pacira Pharmaceuticals
Employees at Pacira Pharmaceuticals rate their CEO, Dave Stack, 48/100.